Join us to hear from Justin Zook, Co-Leader of the Biomarker and Genomic Sciences Group at NIST on how the MDIC have collaborated to use Genome in a Bottle Consortium (GIAB) cell lines to develop reference samples for oncology. You’ll also learn how Revvity has introduced an end-to-end NGS solution portfolio, leveraging Revvity’s Omics CLIA, CAP, NY State clinically validated pipeline, to support lab’s needs from sample extraction to data analysis for genome and exomes. Solution deployment includes options for service backup to minimize the risk of disruptions to essential services. Collaborate with Revvity to advance research and support the development of innovative healthcare solutions.
